The graft survival of rate of anti-HBc (+) grafts was significantly worse than that of anti-HBc (-) grafts, both by unadjusted comparison or after adjustment, although DNHB infection was well-controlled under our protocol or by those of other published strategies. Here, KRT88P is linked to infection.